Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helgo Magnussen

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Respiratory Medicine|August 8, 2006
Association of depression and anxiety with health care use and quality of life in asthma patientsAntje Kullowatz, Frank Kanniess, Bernhard Dahme, et al.
Therapeutic Advances in Respiratory Disease|July 2, 2011
Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary diseaseClaus Vogelmeier, Helgo Magnussen, Craig LaForce, et al.
Annals of the American Thoracic Society|March 21, 2018
The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of the FEV<sub>1</sub>/FVC RatioCarlos A Vaz Fragoso, Helgo Magnussen, Martin R Miller, et al.
Chest|April 12, 2002
Assessment of lymph node tuberculosis in northern Germany: a clinical reviewHenning Geldmacher, Christian Taube, Clemens Kroeger, et al.
American Journal of Respiratory and Critical Care Medicine|November 7, 2017
Spirometry Variability Must Be Critically Interpreted before Negating a Clinical Diagnosis of Chronic Obstructive Pulmonary DiseaseHelgo Magnussen, Carlos A Vaz Fragoso, Martin R Miller, et al.
Biological Psychology|July 20, 2011
The impact of affective states on the perception of dyspnea in patients with chronic obstructive pulmonary diseaseAndreas von Leupoldt, Karin Taube, Maren Henkhus, et al.
Chest|April 2, 2011
The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPDAndreas von Leupoldt, Karin Taube, Kirsten Lehmann, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2017
Spirometry-based Diagnostic Criteria That Are Not Age-Appropriate Lack Clinical RelevanceCarlos A Vaz Fragoso, Helgo Magnussen, Martin R Miller, et al.
COPD|November 10, 2017
Triple Therapy in COPD: What We Know and What We Don'tPeter M A Calverley, Helgo Magnussen, Marc Miravitlles, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2014
Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory studyAnne-Marie Kirsten, Henrik Watz, Caterina Brindicci, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Respiratory Medicine|August 8, 2006
Association of depression and anxiety with health care use and quality of life in asthma patientsAntje Kullowatz, Frank Kanniess, Bernhard Dahme, et al.
Therapeutic Advances in Respiratory Disease|July 2, 2011
Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary diseaseClaus Vogelmeier, Helgo Magnussen, Craig LaForce, et al.
Annals of the American Thoracic Society|March 21, 2018
The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of the FEV<sub>1</sub>/FVC RatioCarlos A Vaz Fragoso, Helgo Magnussen, Martin R Miller, et al.
Chest|April 12, 2002
Assessment of lymph node tuberculosis in northern Germany: a clinical reviewHenning Geldmacher, Christian Taube, Clemens Kroeger, et al.
American Journal of Respiratory and Critical Care Medicine|November 7, 2017
Spirometry Variability Must Be Critically Interpreted before Negating a Clinical Diagnosis of Chronic Obstructive Pulmonary DiseaseHelgo Magnussen, Carlos A Vaz Fragoso, Martin R Miller, et al.
Biological Psychology|July 20, 2011
The impact of affective states on the perception of dyspnea in patients with chronic obstructive pulmonary diseaseAndreas von Leupoldt, Karin Taube, Maren Henkhus, et al.
Chest|April 2, 2011
The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPDAndreas von Leupoldt, Karin Taube, Kirsten Lehmann, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2017
Spirometry-based Diagnostic Criteria That Are Not Age-Appropriate Lack Clinical RelevanceCarlos A Vaz Fragoso, Helgo Magnussen, Martin R Miller, et al.
COPD|November 10, 2017
Triple Therapy in COPD: What We Know and What We Don'tPeter M A Calverley, Helgo Magnussen, Marc Miravitlles, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2014
Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory studyAnne-Marie Kirsten, Henrik Watz, Caterina Brindicci, et al.
Pageof 13